These costs could instead be redirected to deliver new, increasingly effective treatments like GLP-1RAs to those most in need, reducing the burden of substance abuse for communities across the country.
In the SKYLIGHT 1 trial, which included 522 women, fezolinetant demonstrated efficacy in reducing hot flashes in menopausal and perimenopausal women, with a 58% and 61% decrease at a dosage of 30 mg and 45 mg, respectively, after 12 weeks of treatment
Not because they are a trend, but because when used appropriately and under clinical guidance, they can serve as a meaningful complement to a broader wellness or weight management plan
Full dissolution normally takes a few minutes
Candidates for research or therapeutic application include those with primary or secondary insomnia, difficulty initiating or maintaining sleep, or disrupted circadian rhythms
While they use the same active ingredients as the branded versions, the final compounded preparation itself does not go through the same FDA New Drug approval process as the branded or generic versions